A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension

Author:

Kylhammar David1,Kjellström Barbro2,Hjalmarsson Clara3,Jansson Kjell4,Nisell Magnus5,Söderberg Stefan6,Wikström Gerhard7,Rådegran Göran1

Affiliation:

1. Department of Clinical Sciences Lund, Cardiology, Lund University, and The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Skåne University Hospital, Lund, Sweden

2. Cardiology Unit, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden

3. Department of Cardiology, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden

4. Departments of Cardiology and Clinical Physiology, Institution of Medicine and Health Sciences, Linköping University, Linköping, Sweden

5. Department of Medicine Solna, Karolinska Institute, and The Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden

6. Department of Public Health and Clinical Medicine, Heart Centre, Umeå University, Umeå, Sweden

7. Department of Medical Sciences, Cardiology, Uppsala University, and Uppsala Academic Hospital, Uppsala, Sweden

Funder

Bayer Health Care

Swedish Association of Local Authorities and Regions

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Survival in pulmonary hypertension in Spain: insights from the Spanish Registry;Escribano-Subias;Eur Respir J,2012

2. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry;Hoeper;Int J Cardiol,2013

3. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension;Humbert;Eur Respir J,2010

4. Changing demographics, epidemiology and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland;Ling;Am J Respir Crit Care Med,2012

5. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014;Rådegran;Scand Cardiovasc J,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3